163 related articles for article (PubMed ID: 25681764)
1. Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma.
Nakamura R; Kayamori K; Oue E; Sakamoto K; Harada K; Yamaguchi A
Biochem Biophys Res Commun; 2015 Mar; 458(4):777-82. PubMed ID: 25681764
[TBL] [Abstract][Full Text] [Related]
2. CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction.
Oue E; Lee JW; Sakamoto K; Iimura T; Aoki K; Kayamori K; Michi Y; Yamashiro M; Harada K; Amagasa T; Yamaguchi A
Biochem Biophys Res Commun; 2012 Aug; 424(3):456-61. PubMed ID: 22771802
[TBL] [Abstract][Full Text] [Related]
3. RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer.
Sato K; Lee JW; Sakamoto K; Iimura T; Kayamori K; Yasuda H; Shindoh M; Ito M; Omura K; Yamaguchi A
Am J Pathol; 2013 May; 182(5):1890-9. PubMed ID: 23499553
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.
Tohyama R; Kayamori K; Sato K; Hamagaki M; Sakamoto K; Yasuda H; Yamaguchi A
J Oral Pathol Med; 2016 May; 45(5):356-64. PubMed ID: 26859422
[TBL] [Abstract][Full Text] [Related]
5. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
6. Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6.
Yasui T; Kadono Y; Nakamura M; Oshima Y; Matsumoto T; Masuda H; Hirose J; Omata Y; Yasuda H; Imamura T; Nakamura K; Tanaka S
J Bone Miner Res; 2011 Jul; 26(7):1447-56. PubMed ID: 21305609
[TBL] [Abstract][Full Text] [Related]
7. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
8. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
9. Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells.
Kayamori K; Sakamoto K; Nakashima T; Takayanagi H; Morita K; Omura K; Nguyen ST; Miki Y; Iimura T; Himeno A; Akashi T; Yamada-Okabe H; Ogata E; Yamaguchi A
Am J Pathol; 2010 Feb; 176(2):968-80. PubMed ID: 20035059
[TBL] [Abstract][Full Text] [Related]
10. Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad signaling pathway.
Peng H; Shintani S; Kim Y; Wong DT
Neoplasia; 2006 Dec; 8(12):1028-36. PubMed ID: 17217620
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in suppression of osteoclast supportive activity by transforming growth factor-β1 via the ubiquitin-proteasome system.
Inoue M; Nagai-Yoshioka Y; Yamasaki R; Kawamoto T; Nishihara T; Ariyoshi W
PLoS One; 2022; 17(2):e0262612. PubMed ID: 35196318
[TBL] [Abstract][Full Text] [Related]
12. Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption.
Hwang YS; Lee SK; Park KK; Chung WY
Oral Oncol; 2012 Jan; 48(1):40-8. PubMed ID: 21925926
[TBL] [Abstract][Full Text] [Related]
13. The downregulation of IGFBP3 by TGF-β signaling in oral cancer contributes to the osteoclast differentiation.
Park J; Jung MJ; Chung WY
Biochem Biophys Res Commun; 2021 Jan; 534():381-386. PubMed ID: 33256984
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
[TBL] [Abstract][Full Text] [Related]
15. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K
Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755
[TBL] [Abstract][Full Text] [Related]
16. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
[TBL] [Abstract][Full Text] [Related]
17. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
[TBL] [Abstract][Full Text] [Related]
18. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.
Sambandam Y; Ethiraj P; Hathaway-Schrader JD; Novince CM; Panneerselvam E; Sundaram K; Reddy SV
J Cell Physiol; 2018 Aug; 233(8):6125-6134. PubMed ID: 29323724
[TBL] [Abstract][Full Text] [Related]
19. Sonic hedgehog signaling promotes growth of oral squamous cell carcinoma cells associated with bone destruction.
Honami T; Shimo T; Okui T; Kurio N; Hassan NM; Iwamoto M; Sasaki A
Oral Oncol; 2012 Jan; 48(1):49-55. PubMed ID: 21945071
[TBL] [Abstract][Full Text] [Related]
20. [Expression of transforming growth factor beta(TGF-beta) subtypes in oral squamous cell carcinoma].
Jin X; Li J; Li Z; Li Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Dec; 19(6):377-9. PubMed ID: 12539688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
